Mirabella Financial Services LLP Has $2.71 Million Stock Position in Elevance Health, Inc. $ELV

Mirabella Financial Services LLP increased its holdings in shares of Elevance Health, Inc. (NYSE:ELV) by 186.6% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 8,413 shares of the company’s stock after acquiring an additional 5,478 shares during the quarter. Mirabella Financial Services LLP’s holdings in Elevance Health were worth $2,713,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in ELV. Vanguard Group Inc. grew its stake in Elevance Health by 0.6% in the third quarter. Vanguard Group Inc. now owns 22,998,645 shares of the company’s stock valued at $7,431,322,000 after acquiring an additional 141,747 shares during the period. Wellington Management Group LLP lifted its holdings in shares of Elevance Health by 4.8% during the 3rd quarter. Wellington Management Group LLP now owns 6,621,297 shares of the company’s stock valued at $2,139,473,000 after purchasing an additional 303,099 shares in the last quarter. Artisan Partners Limited Partnership lifted its holdings in shares of Elevance Health by 24.5% during the 3rd quarter. Artisan Partners Limited Partnership now owns 4,576,805 shares of the company’s stock valued at $1,478,857,000 after purchasing an additional 901,626 shares in the last quarter. First Eagle Investment Management LLC increased its stake in Elevance Health by 25.0% during the 3rd quarter. First Eagle Investment Management LLC now owns 3,998,603 shares of the company’s stock worth $1,292,029,000 after purchasing an additional 798,457 shares in the last quarter. Finally, Norges Bank acquired a new stake in Elevance Health during the 2nd quarter worth approximately $1,148,379,000. 89.24% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several research firms have recently weighed in on ELV. Guggenheim reduced their price target on shares of Elevance Health from $414.00 to $396.00 and set a “buy” rating for the company in a report on Thursday, January 29th. UBS Group set a $400.00 target price on Elevance Health in a report on Thursday, January 29th. Jefferies Financial Group dropped their price target on Elevance Health from $401.00 to $395.00 and set a “buy” rating on the stock in a research note on Friday, January 30th. Truist Financial reduced their price objective on Elevance Health from $400.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, February 2nd. Finally, Leerink Partners increased their price objective on Elevance Health from $350.00 to $357.00 and gave the stock a “market perform” rating in a report on Thursday, January 29th. Twelve research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $387.40.

Elevance Health Stock Performance

NYSE ELV opened at $291.94 on Tuesday. Elevance Health, Inc. has a 1 year low of $273.71 and a 1 year high of $458.75. The firm has a market capitalization of $64.43 billion, a P/E ratio of 11.62, a price-to-earnings-growth ratio of 1.61 and a beta of 0.51. The firm’s fifty day moving average price is $336.82 and its two-hundred day moving average price is $334.32. The company has a current ratio of 1.54, a quick ratio of 1.54 and a debt-to-equity ratio of 0.70.

Elevance Health (NYSE:ELV) last posted its earnings results on Wednesday, January 28th. The company reported $3.33 earnings per share for the quarter, topping analysts’ consensus estimates of $3.10 by $0.23. The business had revenue of $49.31 billion for the quarter, compared to analyst estimates of $49.52 billion. Elevance Health had a return on equity of 15.59% and a net margin of 2.84%.The firm’s revenue was up 9.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $3.84 EPS. Elevance Health has set its FY 2026 guidance at 25.500- EPS. As a group, research analysts anticipate that Elevance Health, Inc. will post 33.96 EPS for the current year.

Elevance Health Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 25th. Shareholders of record on Tuesday, March 10th will be issued a $1.72 dividend. The ex-dividend date of this dividend is Tuesday, March 10th. This represents a $6.88 dividend on an annualized basis and a yield of 2.4%. This is a positive change from Elevance Health’s previous quarterly dividend of $1.71. Elevance Health’s payout ratio is currently 27.39%.

Elevance Health Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.